United States: Hospitals, Doctors (And Others) Beware: DOJ May Apply Travel Act To Healthcare Prosecutions

Jonathan N. Halpern is a Partner in Holland & Knight's New York office.

Jenna C Bigornia is Partner in Holland & Knight's Boston office

Ilenna J Stein is Associate in Holland & Knight's Boston office


  • A recent federal jury verdict in Dallas affirms the U.S. Department of Justice's determination to extend federal prosecutions to healthcare arrangements involving commercial payers by utilizing the federal Travel Act, which was predicated in this case on underlying state commercial bribery law.
  • The use of the Travel Act for criminal prosecutions in private healthcare cases reflects greater scrutiny of healthcare system practices by federal prosecutors and an increasingly aggressive approach to enforcing the healthcare laws criminally against all system participants, including surgeons, primary care physicians, healthcare administrators, consultants and investors.

Doctors, hospitals and others in the healthcare space should take to heart the increasingly aggressive position the U.S. Department of Justice (DOJ) is taking, including through an expansive application of state bribery laws under the Travel Act, in bringing federal healthcare prosecutions. In its prosecutions, the government is not limiting its focus to arrangements with government-funded programs, such as Medicare and Medicaid, but is using the Travel Act to extend its prosecutorial reach to private insurance matters as well. Federal prosecutors have begun relying on local commercial bribery laws of individual states to bring indictments in cases involving questionable patient referral arrangements. A recent verdict involving the Forest Park Medical Center (FPMC), a physician-owned surgical hospital in Dallas, highlights the scrutiny that healthcare practices may face and the extended tools federal prosecutors will reach for to drop the hammer on healthcare referral practices that, in their view, are improper. This month, following a jury trial in United States v. Beauchamp, et al., 3-16 Cr. 516D (NDTX), seven defendants, including surgeons, other healthcare providers and an FPMC managing director, were convicted of conspiracy to pay or receive healthcare bribes for arranging patient referrals. Ten defendants previously had pled guilty.

Summary of the FPMC Charges

In a sweeping indictment of 21 defendants, federal prosecutors in the Northern District of Texas alleged in seven counts of Travel Act violations – and in 13 more counts – that FPMC, through its owners and managers, paid approximately $40 million in bribes and kickbacks to surgeons and other medical providers in a fraudulent patient referral scheme from 2009 to 2013, and collected more than $200 million in more than a half-billion dollars in billings.

According to the indictment, FPMC capitalized on out-of-network financial arrangements with insurance carriers by setting its own prices for medical services and being "reimbursed at substantially higher rates than in-network providers." Referred patients allegedly were assured that they would "receive in-network benefits" and did not have to pay out-of-network costs – even though FPMC billed the patients' plans and programs at the higher out-of-network rates. To further induce these patients, the FPMC allegedly did not collect patients' coinsurance payments. Most of the affected payers were private, but the government identified TRICARE and the Federal Employees' Compensation Act, federally funded programs, as additionally impacted payers.

To effect the scheme's objectives, as charged, surgeons and others received bribes and kickbacks for referring such patients to the FPMC for medical procedures or to surgeons who operated there. The government alleged that surgeries and referrals were tracked so that bribe and kickback recipients could be "credit[ed]," and payments were made indirectly through shell companies created under sham marketing agreements. In addition to cash and check payments, advertising services, sporting event tickets, expensive meals, discounts on diamonds and opportunities to invest in FPMC also were purportedly provided in exchange for referrals.

A companion element of the scheme was referring Medicare and Medicaid patients and others with "lower-reimbursing insurance coverage" to other non-FPMC facilities in exchange for cash. According to the government, the effect on patients' insurance plans was direct and stark: the plans ended up paying many multiples of what the charges – for the same surgeries by the same surgeons – would have been at in-network facilities.

At the heart of the government's case was a broad conspiracy count based on violations of the anti-kickback statute (AKS) and the Travel Act, as the objects of the conspiracy. The indictment also includes 17 counts of illegal kickbacks and violations of the Travel Act, based on commercial bribery (and aiding and abetting), as well as two money laundering conspiracies. The government also sought forfeiture of the proceeds. Notwithstanding the scope of the fraudulent conduct alleged, conspicuously absent is a charge of the comprehensive healthcare fraud statute – 18 U.S.C. Section 1347 – which encompasses schemes to defraud and false representations to obtain money in connection with a healthcare system. Nor is the statute included as an object of the charged conspiracy. Even though Section 1347 encompasses public and private health plans, prosecutors chose instead to turn to the AKS and the Travel Act for its extensive prosecution.

Expansive Prosecutions with the Travel Act

The FPMC indictment leans heavily on the Travel Act, 18 U.S.C. Section 1952, in its charges against doctors, administrators and others. That federal statute, in turn, relies on the predicate of commercial bribery under state law as the basis for the charged "unlawful activity." Under the Travel Act, it is illegal to use a facility in interstate commerce (such as email, a wire between states or the federal banking system) with the intent, among other things, to distribute the proceeds of "unlawful activity" and thereafter do some act to further the distribution of the proceeds. The Travel Act's definition of "unlawful activity" encompasses bribery under the law of the state in which it was committed; Texas, like many other states, has a commercial bribery law on its books. However, there is no federal commercial bribery statute. The FPMC indictment alleged that co-conspirators used email instructions and a Federal Reserve Bank's computer network (interstate facilities) to send bribe/kickback payments constituting "unlawful activity" (commercial bribery under Texas state law) to a shell company, which thereafter sent hundreds of thousands of dollars in checks for clearance at bank accounts held by the co-conspirators who referred patients to the FPMC.

The government's recent reliance on the broad "unlawful activity" provision of the Travel Act enables prosecutors to consider, as in the FPMC case, whether private, commercial insurance arrangements comply with federal criminal law. The government also has used the Travel Act in a previous healthcare indictment, in New Jersey, involving Biodiagnostic Laboratory Services LLC, where laboratory services were allegedly referred in exchange for bribes. In that case, like here, the statute was charged as both an object of the conspiracy and a substantive crime. (In the FPMC case, however, use of the Travel Act was expanded, extending to seven substantive counts.)

The use of the Travel Act in such cases also is consistent with the full extent of federal resources that the U.S. government brings to bear in managing healthcare investigations. For example, it is extraordinary (but perhaps no longer shocking) that the FPMC case was investigated not only by the FBI, but also by the U.S. Office of Personnel Management (Office of Inspector General), U.S. Department of Labor (both Office of Inspector General and Employment Benefits Security Administration), U.S. Department of Defense (Criminal) and Internal Revenue Service (Criminal), "with assistance" from the U.S. Food and Drug Administration (Criminal Investigations).1

Traditional Applications of Federal Statutes in Healthcare Prosecutions

Traditionally, healthcare referral practices attracting the attention of government prosecutors and agents have involved federal healthcare programs, such as Medicare, Medicaid and TRICARE. The federal government often enforces cases involving bribes, kickbacks or unlawful arrangements for healthcare services and items, criminally and civilly, through the federal False Claims Act (sometimes with state law allegations as the underlying conduct), AKS, Stark Law, Civil Monetary Penalty laws or other federal laws. Under the AKS, it generally is a crime, among other things, to offer, pay, solicit or receive remuneration – anything of value, in whatever form – directly or indirectly, in exchange for referring a patient for medical items or procedures provided and paid for at least partially under a federal healthcare program. Patient referral cases involving private insurance often have eluded prosecutorial scrutiny as outside the AKS and beyond federal jurisdiction. Of course, prosecutors have long relied on an arsenal of other criminal statutes to address an array of healthcare violations, including the general healthcare fraud statute for a wide range of healthcare system-related fraudulent offenses. These include false and fraudulent means to obtain money from, or a scheme to defraud, a healthcare benefit program – defined to cover both public and private plans and contracts affecting commerce. (18 U.S.C. Section 1347). Mail fraud and wire fraud statutes historically also have been used. (18 U.S.C. Sections 1341 and 1343).

Takeaway Points

In light of the DOJ's strict enforcement of the criminal healthcare laws, especially with aggressive and nontraditional methods, consider, among others, the following takeaway points:

  • While the AKS may be implicated where a federal healthcare program is involved, healthcare companies should be aware of the federal government's application of the Travel Act to conduct that falls outside of the AKS. In the FPMC prosecution, there was myriad allegedly criminal conduct, some of which was outside of the purview of the AKS, so prosecutors relied on Texas state law that prohibits commercial bribery as the hook to apply the federal Travel Act to activity that was similar, although not subject to the AKS.
  • Although not every arrangement will likely be covered by the Travel Act, as healthcare companies undertake to structure arrangements – and draft corresponding agreements – they would be well served to carefully consider the potential implications of their proposed practices under applicable state and federal law.
  • Healthcare companies and providers should conduct due diligence, auditing and monitoring, as appropriate, with particular attention to payment systems, to ensure that they are adhering to applicable law, their own compliance policies and existing agreements.
  • Healthcare companies should take note that investigation by a civil or regulatory agency may readily develop into a criminal investigation as well.

It is apparent that the DOJ, assisted by other agencies – and increasingly prodded by whistleblowers – can be counted on to step up its scrutiny of healthcare systems and aggressively apply the law, including the Travel Act, in healthcare prosecutions going forward. Accordingly, healthcare companies could timely profit from a reevaluation of their current programs and practices.

Clients needing more information or guidance regarding protection under the Travel Act or the healthcare laws generally may contact the authors.


1 For years, prosecutors also have been using the Travel Act in international bribery cases, where prosecution under the Foreign Corrupt Practices Act (FCPA) does not extend to the bribe recipient, such as a "foreign official." Increasingly, prosecutors have used the Travel Act as a prosecutorial complement to the FCPA in seeking to hold both bribe payer and recipient criminally accountable.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions